- Home
- PRVA
as 02-21-2025 4:00pm EST
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Upcoming Earnings Alert:
Get ready for potential market movements as Privia Health Group Inc. PRVA prepares to release earnings report on 27 Feb 2025.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.8B | IPO Year: | 2021 |
| Target Price: | $24.71 | AVG Volume (30 days): | 587.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | -64.75 |
| 52 Week Low/High: | $15.92 - $25.67 | Next Earning Date: | 02-27-2025 |
| Revenue: | $1,716,318,000 | Revenue Growth: | 8.54% |
| Revenue Growth (this year): | 78.5% | Revenue Growth (next year): | 11.52% |
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
PRVA: Raising target price to $26.00
Insider Monkey
8 days ago
Privia Health Group, Inc. (PRVA): Among the Health Information Services Stocks Outpacing the Market in 2025
Simply Wall St.
11 days ago
3 US Stocks Estimated To Be Up To 46.6% Below Intrinsic Value
Argus Research
18 days ago
PRVA: What does Argus have to say about PRVA?
Argus Research
25 days ago
PRVA: What does Argus have to say about PRVA?
GlobeNewswire
a month ago
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
Simply Wall St.
a month ago
An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 49% Undervalued
Argus Research
a month ago
PRVA: Raising target price to $24.00
Compare PRVA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.